Early research (Phase 1)Study completedNCT02501902What this trial is testingDose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDACWho this might be right forMetastatic Pancreatic Ductal Adenocarcinoma Pfizer 76
Early research (Phase 1)Ended earlyNCT02650635What this trial is testingTLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsWho this might be right forColorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Breast Carcinoma+14 more Mayo Clinic 4
Testing effectiveness (Phase 2)Ended earlyNCT01562899What this trial is testingMEK162 and AMG 479 in Patients With Selected Solid TumorsWho this might be right forMetastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma Pfizer 77
Testing effectiveness (Phase 2)Temporarily pausedNCT04111172What this trial is testingA Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal AdenocarcinomaWho this might be right forPancreatic Ductal AdenocarcinomaColorectal AdenocarcinomaGastric Adenocarcinoma+35 more Thomas Jefferson University 48
Large-scale testing (Phase 3)Study completedNCT00960284What this trial is testingGemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic CancerWho this might be right forPancreatic Cancer IRCCS San Raffaele 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827953What this trial is testingStudy to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic CancerWho this might be right forPancreatic Ductal Adenocarcinoma Nelum Corp 28
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07475234What this trial is testingRimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forMetastatic Pancreatic Ductal Adenocarcinoma Xiuchao Wang 30
Testing effectiveness (Phase 2)Study completedNCT03410030What this trial is testingTrial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)Who this might be right forPancreatic CancerPancreas CancerPancreatic Adenocarcinoma Resectable+2 more HonorHealth Research Institute 17
Early research (Phase 1)Study completedNCT00836407What this trial is testingIpilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Early research (Phase 1)Study completedNCT05867121What this trial is testingEvaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010Who this might be right forNon-small Cell Lung CancerGastric CancerPancreatic Ductal Adenocarcinoma Genentech, Inc. 102
Testing effectiveness (Phase 2)Study completedNCT01234935What this trial is testingDasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With SurgeryWho this might be right forAcinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+5 more Translational Oncology Research International 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175389What this trial is testingJDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment FailureWho this might be right forRefractory Pancreatic Ductal AdenocarcinomaRefractory Pancreatic Adenocarcinoma West China Hospital 10
Testing effectiveness (Phase 2)WithdrawnNCT01473303What this trial is testingCombination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Alliance for Clinical Trials in Oncology
Early research (Phase 1)Study completedNCT01010945What this trial is testingErlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic CancerWho this might be right forAdvanced Pancreatic Cancer OSI Pharmaceuticals 19
Not applicableStudy completedNCT02511821What this trial is testingElectronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryWho this might be right forStage I Adult Liver CancerStage I Colorectal CancerStage IA Gastric Cancer+28 more City of Hope Medical Center 22
Testing effectiveness (Phase 2)UnknownNCT04216758What this trial is testingNab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic CancerWho this might be right forStage IA Pancreatic AdenocarcinomaStage IB Pancreatic AdenocarcinomaStage IIA Pancreatic Adenocarcinoma+1 more Fudan University 300
Early research (Phase 1)Active Not RecruitingNCT04627246What this trial is testingPersonalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic CancerWho this might be right forPancreatic Adenocarcinoma Centre Hospitalier Universitaire Vaudois 14
Testing effectiveness (Phase 2)WithdrawnNCT02575508What this trial is testingPan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerWho this might be right forColon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more Roswell Park Cancer Institute
Early research (Phase 1)Ended earlyNCT05417386What this trial is testingFOLFIRINOX + NIS793 in Pancreatic CancerWho this might be right forPancreas CancerMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma Colin D. Weekes, M.D., PhD 4